SyntekaBio Inc

226330

Company Profile

  • Business description

    SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

  • Contact

    187, Techno 2-ro
    Yuseong-gu, Bi-dong
    Yongsan-dong, Megan Techno World 2nd
    Daejeon512
    KOR

    T: +82 7076630958

    http://www.syntekabio.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Health Information Services

    Fiscal Year End

    31 December 2025

    Employees

    52

Stocks News & Analysis

stocks

Overvalued ASX mining giant

Solid start to 2026 but shares overvalued.
stocks

Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?

With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.
stocks

Tesla earnings: Shares fall as market focuses on uncertainty in near term

Are shares overpriced despite the fall?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,317.2026.50-0.28%
CAC 408,176.8648.92-0.59%
DAX 4024,194.2813.51-0.06%
Dow JONES (US)46,734.61144.200.31%
FTSE 1009,576.611.96-0.02%
HKSE26,160.15192.170.74%
NASDAQ22,941.80201.400.89%
Nikkei 22549,299.65658.041.35%
NZX 50 Index13,391.5914.490.11%
S&P 5006,738.4439.040.58%
S&P/ASX 2009,019.0025.20-0.28%
SSE Composite Index3,950.3127.900.71%

Market Movers